• 

  US FDA clears Pfizer's Covid-19 vaccine for kids aged between 5 and 11 years

  World | October 30, 2021 11:32 IST

  With FDA's action, Pfizer plans to begin shipping millions of vials of the pediatric vaccine — in orange caps to avoid mix-ups with the purple-capped doses for everyone else — to doctors' offices, pharmacies and other vaccination sites. Kids will get two shots, three weeks apart.

• 

  FDA backs Pfizer COVID-19 vaccine for kids between 5 to 11 years of age

  World | October 27, 2021 7:20 IST

  The FDA isn’t bound by the panel’s recommendation and is expected to make its own decision within days.

• 

  US to reopen land borders in November for fully vaccinated

  World | October 13, 2021 16:43 IST

  The vaccination requirement for foreign nationals comes as the White House has moved to impose sweeping vaccination-or-testing requirements.

• 

  Pfizer Covid vaccine for kids may not be available until November

  World | September 29, 2021 7:00 IST

  The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old.

• 

  FDA backs Pfizer COVID boosters for seniors, high-risk

  World | September 23, 2021 14:39 IST

  The FDA authorized booster doses for Americans who are 65 and older, younger adults with underlying health conditions and those in jobs that put them at high risk for COVID.

• 

  Pfizer COVID-19 vaccine safe for children aged 5-11, confirms clinical trial results

  World | September 21, 2021 9:49 IST

  Pfizer COVID-19 vaccine is safe for children aged 5-11, confirms clinical trial results, reports AFP

• 

  US panel backs COVID-19 boosters only for seniors, high-risk

  World | September 18, 2021 6:47 IST

  An influential federal advisory panel overwhelmingly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.

• 

  Pfizer to offer small Covid vaccine packaging to cut wastage of doses

  World | September 06, 2021 19:36 IST

  Currently, Pfizer's mRNA Covid vaccine is available in two packages: one with 450 doses and another with 1,170. But the vaccine's cold storage requirement limits where and for how long they can be kept, making it challenging for smaller facilities to store high quantities of the vaccine without wasting doses.

• 

  Pfizer Covid booster shot likely to start by September 20 in US: Fauci

  World | September 06, 2021 15:35 IST

  Even as the approvals are pending, the Joe Biden administration has announced plans to offer third doses to people who received the Pfizer and Moderna shots.  

• 

  First death due to Pfizer vaccine's 'rare side effect' reported in New Zealand

  World | August 30, 2021 10:25 IST

  The case has been referred to the coroner and the cause of death has not yet been determined, the health ministry said. 

• 

  What does full approval of Pfizer’s COVID-19 vaccine mean?

  World | August 24, 2021 13:19 IST

  Pfizer’s vaccine — along with those from Moderna and Johnson & Johnson — still underwent testing in tens of thousands of people to establish safety and effectiveness against COVID-19.

Advertisement
• 

  US regulators give full approval to Pfizer COVID-19 vaccine

  World | August 23, 2021 19:36 IST

  The U.S. gave full approval to Pfizer’s COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet.

• 

  Moderna 76% effective against Covid-19 Delta variant, Pfizer 42%: Study

  Science | August 12, 2021 16:35 IST

  Researchers from the Mayo Clinic in Minnesota, US, found that the Pfizer-BioNTech vaccine was only 42 percent effective against infection in July, while the Moderna vaccine was only 76 percent effective.

• 

  3rd COVID vaccine dose strongly boosts protection against Delta variant: Pfizer

  World | July 29, 2021 7:35 IST

  Antibody levels against the Delta variant in people aged 18 to 55 who receive a third dose of the Pfizer/BioNTech vaccine are greater than five-fold than following a second dose, according to data posted at the company's teleconference, Xinhua reported.

• 

  Antibodies drop 50% in 3 months of Pfizer, AstraZeneca jabs: Study

  World | July 27, 2021 13:30 IST

  The study, led by researchers of University College London, showed that waning effect of the vaccine doses were consistent across all groups of people regardless of age, chronic illnesses or sex.

• 

  Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study

  World | July 24, 2021 21:37 IST

  The study, led by the University of Oxford, in collaboration with the Universities of Birmingham, Newcastle, Liverpool, Sheffield, and supported by the UK Coronavirus Immunology Consortium, is one of the most comprehensive studies into the immune response generated by the Pfizer COVID-19 vaccine to date.

• 

  Thousands protest against lockdown in Sydney

  World | July 24, 2021 19:24 IST

  There was a heavy police presence in Sydney, including mounted police and riot officers in response to what authorities said was unauthorized protest activity. Police confirmed a number of arrests had been made after objects were thrown at officers.

• 

  FDA adds warning of rare reaction risk to J&J Covid vaccine

  World | July 13, 2021 7:43 IST

  US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem.

• 

  Pfizer to discuss vaccine booster with US officials on Monday

  World | July 12, 2021 12:01 IST

  Pfizer says it plans to meet with top US health officials Monday to discuss the drugmaker's request for federal authorization of a third dose of its COVID-19 vaccine.

• 

  Pfizer to seek OK for 3rd vaccine dose; shots still protect

  World | July 09, 2021 7:10 IST

  Research from multiple countries shows the Pfizer shot and other widely used COVID-19 vaccines offer strong protection against the highly contagious delta variant, which is spreading rapidly around the world and now accounts for most new U.S. infections.